What HLA-B27 Means in Your 23andMe Raw Data

No. 23andMe raw data does not sequence your HLA-B gene, so it cannot directly call HLA-B27. What it can do is read a nearby tag SNP, usually rs4349859, that is linked to HLA-B27 in European-ancestry populations. A positive tag SNP raises the probability that you carry HLA-B27. It is not a blood test and cannot diagnose ankylosing spondylitis.

Does 23andMe raw data test for HLA-B27?

In your raw file, you will not find HLA-B27 as a result. The HLA-B gene has thousands of alleles, and the 23andMe chip does not sequence them. The chip reads a fixed set of single nucleotide polymorphisms. One of those, rs4349859, sits near HLA-B and is inherited with HLA-B27 often enough to be useful in some populations. You can search your raw data for rs4349859. What you see will look like a genotype call, such as A/A, A/G, or G/G, plus a chromosome and position. It will not say 'HLA-B27 positive'.

Current 23andMe chips include rs4349859. You may still see a no-call if the read fails. If the marker is absent from your file, that is not evidence you are HLA-B27 negative. It just means the chip did not read that marker.

The tag SNP is a street sign, not the destination. It says 'HLA-B27 is common near this marker in some populations', not 'you carry HLA-B27'.

Why a tag SNP is only a pointer

HLA-B sits in the major histocompatibility complex on chromosome 6. This region is dense and inherited in blocks. Because recombination there is uneven, alleles at nearby markers often travel together. rs4349859 can tag HLA-B27 because, in European-ancestry populations, the risk-associated A allele at rs4349859 tends to appear on the same chromosome as HLA-B27.

The mechanism matters because it explains where the method weakens. In African, East Asian, South Asian, or mixed-ancestry genomes, the same marker may not track HLA-B27 as tightly. A result that is meaningful in one ancestry can be much less informative in another. The raw data does not know your ancestry when it calls the genotype; you have to apply that context yourself.

What the numbers look like

Roughly 90% of people with ankylosing spondylitis carry HLA-B27. But only around 5% of HLA-B27 carriers ever develop ankylosing spondylitis. In people of European ancestry, HLA-B27 is present in about 8% of the general population, though prevalence varies by region.

These numbers are the reason a positive result is not a diagnosis. The marker is common enough that many carriers never develop the condition; the disease is possible in people without HLA-B27.

What you actually see in your raw data

If your file includes rs4349859, the genotype will be one of three combinations:

• A/A: two copies of the risk-associated tag allele.
• A/G: one copy of the risk-associated tag allele and one copy of the other allele.
• G/G: no copies of the risk-associated tag allele.

The risk-associated allele is often reported as A at rs4349859. If you carry one or two copies, your probability of carrying HLA-B27 is higher if you have European ancestry. It is still not proof. If you are G/G, HLA-B27 is much less likely, but not impossible, because a tag SNP can miss rare recombinations.

The common mistake is to read A/A as 'I have HLA-B27' or 'I have ankylosing spondylitis'. It means neither. It means the linked marker is present. A clinical HLA-B27 test looks for the actual HLA-B27 protein or allele on white blood cells.

If the tag SNP is positive, do you need the blood test?

The clinical laboratory test is the definitive standard way to confirm HLA-B27 status. The blood test detects the actual HLA-B27 protein on your cells, or the DNA sequence that encodes it. It is ordered as a blood test, not a spit kit.

A positive clinical HLA-B27 test still does not diagnose ankylosing spondylitis. The diagnosis depends on symptoms, imaging, and sometimes other blood markers. The classic pattern is inflammatory back pain: worse after rest, better with movement, morning stiffness lasting more than 30 minutes. HLA-B27 also turns up in some people with acute anterior uveitis, reactive arthritis, and some forms of psoriatic arthritis.

If the tag SNP is positive and you have those symptoms, ask a doctor or rheumatologist about an HLA-B27 blood test. If the tag SNP is positive and you have no symptoms, the blood test is not automatically necessary. The more useful input is a conversation about your actual joints, eyes, gut, and family history.

What a negative result can and cannot tell you

A G/G genotype at rs4349859 lowers the probability that you carry HLA-B27 in European-ancestry populations. It does not eliminate it. In non-European ancestries, the tag SNP may be unreliable in either direction. If you have symptoms, a negative raw-data result should not stop you from getting a proper clinical test. If you have no symptoms, a negative result is reassuring but changes little about your day-to-day risk.

Where the evidence thins

The tag SNP is validated best in European-ancestry populations. Ancestry matters. The numbers for HLA-B27 prevalence and the strength of the tag vary. Also, HLA-B27 is not one disease gene. It is an immune allele that shifts risk in a complex disease, and most carriers stay well. The raw data is a useful first clue, not a final answer.

healthosx.com/dna

The download steps for 23andMe, on the page itself.

healthosx.com/dna

The short version: what is worth acting on, first.

If you want to see the HLA-B immune type finding in your own raw file without scrolling through rows of genotypes, the free DNA tool at HealthOS reads 23andMe, AncestryDNA, MyHeritage and whole-genome VCF files in the browser and reports an HLA-B immune type linked to back and joint inflammation. The file stays on your device for the trait report. Use it when you want the raw data turned into something you can read.